Feng Yuhui, Yang Xianhong, Huang Yanyan
Department of General Practice, Huashan Hospital, Fudan University, Shanghai, China.
VIP ward, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Arch Psychiatry. 2013 Jun;25(3):178-82. doi: 10.3969/j.issn.1002-0829.2013.03.009.
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening adverse reaction to antipsychotic medication that typically includes high-fever, extrapyramidal symptoms, autonomic nervous system dysfunction and disturbances in consciousness. Though reported to be more common following use of the older, first generation antipsychotic medications, it can also occur in patients taking the newer, second generation antipsychotic medications. This report discusses the clinical presentation, possible etiology, pathogenesis and treatment of two cases of NMS that occurred in elderly patients after taking atypical antipsychotics. With the increasing use of atypical antipsychotic medication in elderly patients - who may be more susceptible to this adverse reaction - there is a need to increase clinical vigilance about this condition, particularly among internists and gerontologists who may be unfamiliar with this rare complication to antipsychotic medication.
神经阻滞剂恶性综合征(NMS)是一种罕见的、危及生命的抗精神病药物不良反应,通常包括高热、锥体外系症状、自主神经系统功能障碍和意识障碍。尽管据报道在使用较老的第一代抗精神病药物后更为常见,但服用较新的第二代抗精神病药物的患者也可能发生。本报告讨论了两例老年患者服用非典型抗精神病药物后发生NMS的临床表现、可能的病因、发病机制及治疗。随着非典型抗精神病药物在老年患者中的使用增加,而这些患者可能更容易出现这种不良反应,因此有必要提高对这种情况的临床警惕性,尤其是在内科医生和老年病医生中,他们可能不熟悉这种抗精神病药物罕见的并发症。